Pentixapharm Holding AG (XTER:PTP) Net Margin %: 0.00% (As of Mar. 2026)


XTER:PTP Pentixapharm Holding AG XTER:PTP
12 GF Score
Price €2.10
! 2 Warning Signs
View Full Analysis

What is Pentixapharm Holding AG Net Margin %?

Pentixapharm Holding AG XTER:PTP +4.48% 12 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates XTER:PTP with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 947 Biotechnology companies, Pentixapharm Holding AG ranks worse than 95.25% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Pentixapharm Holding AG's Net Income for the three months ended in Mar. 2026 was €-3.18 Mil. Pentixapharm Holding AG's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Pentixapharm Holding AG's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Pentixapharm Holding AG's Net Margin % or its related term are showing as below:

XTER:PTP' s Net Margin % Range Over the Past 10 Years
Min: -31829.17   Med: -10883.9   Max: -4223.73
Current: -21187.84

XTER:PTP's Net Margin % is ranked worse than
95.25% of 947 companies
in the Biotechnology industry
Industry Median: -89.33 vs XTER:PTP: -21187.84

Pentixapharm Holding AG  (XTER:PTP) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Pentixapharm Holding AG Net Margin % Related Terms

Pentixapharm Holding AG Net Margin % Historical Data

* Premium members only.

The historical data trend for Pentixapharm Holding AG's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pentixapharm Holding AG Net Margin % Chart

Pentixapharm Holding AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
-4,223.73 -6,325.81 -31,829.17 -10,883.90 -17,753.76

Pentixapharm Holding AG Quarterly Data
Dec21 Dec22 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -21,121.05 -23,094.74 -5,432.91 15,904.17 0.00

XTER:PTP vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Pentixapharm Holding AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pentixapharm Holding AG Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pentixapharm Holding AG's Net Margin % distribution charts can be found below:

* The bar in red indicates where Pentixapharm Holding AG's Net Margin % falls into.


XTER:PTP
12GF Score
Pentixapharm Holding AG XTER:PTP
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pentixapharm Holding AG Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Pentixapharm Holding AG's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-16.511/0.093
=-17,753.76 %

Pentixapharm Holding AG's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-3.182/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Pentixapharm Holding AG (XTER:PTP) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Pentixapharm Holding AG and its competitors. According to the industry distribution chart, Pentixapharm Holding AG ranks #902 out of 947 companies in the Biotechnology industry, placing it in the top 95.2%.
Is Pentixapharm Holding AG's Net Margin % too high?
Pentixapharm Holding AG's current Net Margin % is 0.00%. Based on the distribution chart, Pentixapharm Holding AG ranks #902 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Pentixapharm Holding AG has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Pentixapharm Holding AG's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pentixapharm Holding AG ranks #902 out of 947 companies for Net Margin %. This places Pentixapharm Holding AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Pentixapharm Holding AG and its competitors. Pentixapharm Holding AG's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pentixapharm Holding AG stock overvalued right now?
Pentixapharm Holding AG (XTER:PTP) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Pentixapharm Holding AG's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Pentixapharm Holding AG (XTER:PTP), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pentixapharm Holding AG Business Description

Other Exchanges PTPN:Austria
Address Robert-Rossle-Street 10, Berlin, DEU, 13125
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic. Its Pipeline products include: Pentixa Ther, PT-002, PentixaFor, PT-001, PentixaFor, PT-001, PT-00X, GT-001, GT-002, GT-005, GT-008, and GT-00X.
12GF Score

Get the complete analysis for XTER:PTP

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.10
Price